Cargando…
The Role of Patiromer in Delaying the Onset of Renal Replacement Therapy in Patients with Advanced Renal Failure
Patients with chronic kidney disease (CKD) are at an increased risk of developing hyperkalemia, which can be potentially life threatening. Hyperkalemia is frequently encountered with renin-angiotensin-aldosterone system inhibitor (RAASi) therapy use in patients with CKD and often results in the unde...
Autores principales: | Wadhwa, Nand K., Kline, Jason A., Adapa, Sreedhar R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440084/ https://www.ncbi.nlm.nih.gov/pubmed/34532145 http://dx.doi.org/10.1155/2021/6987456 |
Ejemplares similares
-
COVID-19 and Renal Failure: Challenges in the Delivery of Renal Replacement Therapy
por: Adapa, Sreedhar, et al.
Publicado: (2020) -
Therapeutic Plasma Exchange with Continuous Renal Replacement Therapy for Pediatric Acute Liver Failure: A Case Series from Thailand
por: Trepatchayakorn, Sirawut, et al.
Publicado: (2021) -
Continuous Renal Replacement Therapy (CRRT) for Nonrenal Indications among Critically Ill Children with Malignancy
por: Hui, Wun Fung, et al.
Publicado: (2021) -
Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia
por: Bounthavong, Mark, et al.
Publicado: (2018) -
Patiromer sorbitex calcium for hyperkalaemia
Publicado: (2019)